Doctors at AIIMS, Delhi are developing a low-cost antibody-based adaptive cellular therapy for treatment of multiple myeloma, a form of blood cancer.

Combining phototherapy with chemotherapy may provide a more powerful approach to combat aggressive tumors effectively.

Researchers have successfully developed a modular synthetic translational coupling element (SynTCE), significantly enhancing ...

For CRISPR Therapeutics specifically, that financial flexibility is not necessarily needed even if it's a plus. As of the most recent quarter, Q3, it reported having around $1.9 billion in cash, ...

Taking inspiration from the mechanics of WWI aircraft, this innovation could redefine approaches to cancer and heart disease ...

More than 100 clinical trials put stem cells for regenerative medicine to the test. It’s a turning point for a field beset ...

The company is using its Senza5 platform to produce CAR T cells without the CD5 receptor, hoping to enable smaller doses and avoid CAR-T fratricide.

The FDA granted fast track designation to SC291 as a potential treatment for hard-to-manage systemic lupus erythematosus (SLE).

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science ...

A team of Children's Medical Research Institute (CMRI) scientists has identified a new method for producing a therapeutic ...

Corvus Pharmaceuticals develops next-gen ITK inhibitors, with promising Phase 1 results. Read why CRVS stock can thrive in ...